Literature DB >> 19830549

Recent advances in quantitative EEG as an aid to diagnosis and as a guide to neurofeedback training for cortical hypofunctions, hyperfunctions, disconnections, and hyperconnections: improving efficacy in complicated neurological and psychological disorders.

Jonathan E Walker1.   

Abstract

Recent advances in QEEG-databases have enabled improvements in interpretation, which in turn have led to more effective neurofeedback interventions. These improvements relate mostly to evaluations conducted in the high frequency beta range (21-30 Hz) evaluation and in single Hz bins, which more specifically address which frequencies need to be trained to most quickly and effectively normalize their dysfunctions and remediate their difficulties. Use of the modular activation/coherence model (Walker et al. in J Neurother 11: 25-44, 2007) provides a framework for correcting the slow or fast modular dysfunctions, as well as normalizing connectivity using coherence training.

Entities:  

Mesh:

Year:  2009        PMID: 19830549     DOI: 10.1007/s10484-009-9107-0

Source DB:  PubMed          Journal:  Appl Psychophysiol Biofeedback        ISSN: 1090-0586


  4 in total

1.  Therapeutic Applications of BCI Technologies.

Authors:  Dennis J McFarland; Janis Daly; Chadwick Boulay; Muhammad Parvaz
Journal:  Brain Comput Interfaces (Abingdon)       Date:  2017-04-10

2.  Effects of computer assisted cognitive rehabilitation on brain wave, memory and attention of stroke patients: a randomized control trial.

Authors:  Hwi-Young Cho; Ki-Tae Kim; Jin-Hwa Jung
Journal:  J Phys Ther Sci       Date:  2015-04-30

3.  Possible Mechanisms Underlying Neurological Post-COVID Symptoms and Neurofeedback as a Potential Therapy.

Authors:  Mária Orendáčová; Eugen Kvašňák
Journal:  Front Hum Neurosci       Date:  2022-03-31       Impact factor: 3.473

4.  Effect of neurofeedback therapy on neurological post-COVID-19 complications (A pilot study).

Authors:  Mária Orendáčová; Eugen Kvašňák; Jana Vránová
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.